Alvotech Historical Cash Flow
| ALVO Stock | USD 11.36 0.10 0.87% |
Analysis of Alvotech cash flow over time is an excellent tool to project Alvotech future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Stock Based Compensation of 21.8 M or Change In Working Capital of 24.9 M as it is a great indicator of Alvotech ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Alvotech latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Alvotech is a good buy for the upcoming year.
Alvotech |
About Alvotech Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Alvotech balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Alvotech's non-liquid assets can be easily converted into cash.
Alvotech Cash Flow Chart
Add Fundamental
Net Borrowings
The difference between the amount of new debt a company has taken on and the amount of debt it has paid off during a given period.Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Change In Working Capital
The difference in the amount of working capital from one period to the next, indicating the change in a company's short-term assets and liabilities.Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Capital Expenditures
Capital Expenditures are funds used by Alvotech to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Alvotech operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Most accounts from Alvotech's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Alvotech current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Alvotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. To learn how to invest in Alvotech Stock, please use our How to Invest in Alvotech guide.At this time, Alvotech's Net Borrowings is very stable compared to the past year. As of the 1st of March 2025, Stock Based Compensation is likely to grow to about 21.8 M, while Change To Inventory is likely to drop (10.7 M).
Alvotech cash flow statement Correlations
Click cells to compare fundamentals
Alvotech Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Alvotech cash flow statement Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change To Inventory | (3.3M) | (29.4M) | (32.4M) | (11.3M) | (10.2M) | (10.7M) | |
| Investments | (16.9M) | (40.6M) | (63.5M) | (46.3M) | (41.7M) | (43.8M) | |
| Change In Cash | (35.7M) | (14.1M) | 48.9M | (55.3M) | (49.7M) | (47.3M) | |
| Stock Based Compensation | (5.5M) | (22.3M) | 10.3M | 18.0M | 20.7M | 21.8M | |
| Free Cash Flow | (86.3M) | (268.8M) | (361.4M) | (358.7M) | (322.8M) | (338.9M) | |
| Change In Working Capital | 32.5M | (6.8M) | (47.9M) | 26.3M | 23.7M | 24.9M | |
| Begin Period Cash Flow | 67.4M | 31.7M | 17.6M | 66.4M | 59.8M | 37.7M | |
| Other Cashflows From Financing Activities | 34.4M | (40.6M) | 167.1M | (6.8M) | (6.1M) | (5.8M) | |
| Depreciation | 16.4M | 18.2M | 20.4M | 24.2M | 27.8M | 20.6M | |
| Other Non Cash Items | 174.0M | (68.0M) | 256.4M | 270.3M | 310.8M | 167.5M | |
| Capital Expenditures | 12.0M | 40.6M | 49.0M | 46.5M | 53.4M | 34.4M | |
| Total Cash From Operating Activities | (74.3M) | (228.2M) | (312.4M) | (312.2M) | (281.0M) | (295.0M) | |
| Change To Account Receivables | 21.8M | (28.8M) | (3.6M) | (8.3M) | (9.6M) | (10.0M) | |
| Issuance Of Capital Stock | 34.4M | 185.9M | 119.0M | 136.9M | 157.4M | 111.5M | |
| Net Income | (170.0M) | (101.5M) | (513.6M) | (551.7M) | (496.6M) | (471.7M) | |
| Total Cash From Financing Activities | 55.4M | 254.8M | 424.9M | 301.3M | 346.5M | 253.6M | |
| End Period Cash Flow | 31.7M | 17.6M | 66.4M | 11.2M | 10.0M | 9.5M | |
| Other Cashflows From Investing Activities | 79K | (25K) | (14.9M) | (13.1M) | (11.8M) | (11.2M) |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Alvotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. To learn how to invest in Alvotech Stock, please use our How to Invest in Alvotech guide.You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Alvotech. If investors know Alvotech will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Alvotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.70) | Earnings Share (1.85) | Revenue Per Share | Quarterly Revenue Growth 4.786 | Return On Assets |
The market value of Alvotech is measured differently than its book value, which is the value of Alvotech that is recorded on the company's balance sheet. Investors also form their own opinion of Alvotech's value that differs from its market value or its book value, called intrinsic value, which is Alvotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Alvotech's market value can be influenced by many factors that don't directly affect Alvotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Alvotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Alvotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Alvotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.